be needed to achieve a satisfactory result. The prospect of successful treatment depends upon whether the tumor is still confined within the eye at the time of diagnosis. The prognosis in retinoblastoma depends on the size and location of tumors and the degree of ocular and extraocular involvement. Extension into the orbital tissue, or evidence of metastases, is an indication of a poor prognosis. [4] [5] [6] [7] Reports on retinoblastoma in Indonesia have been scare. We reviewed the clinical characteristics of patients treated at the Department of Child Health, Adam Malik Hospital, Medan since January 1995-December 1999. 
Methods

Subjects
Results
Nineteen retinoblastoma patients were included in this study, from which 9 were males. The average age at diagnosis was 3 years 8 months (range: 1 year 6 months to 6 years), from which 15 patients were diagnosed at the age of less than 5 years. The right eye was equally affected to the left one, i.e. 9 patients who had retinoblastoma of the right eye and 8 had the tumor of the left eye. Only in 2 patients were the tumor involved both eyes on admission. See Table 1 .
Most patients were admitted to the Department of Child Health because of proptosis (14/19), the other 5 patients were referred by ophthalmologists following surgical intervention, i.e. enucleation. It appears that before 1997 children with retinoblastoma were admitted to Ophthalmology Department, while after 1997 they were admitted to the Department of Child Health.
The majority of patients had advanced disease ( Table 2) . The most common primary condition on admission was proptosis, i.e., in 14 patients. From 1995 to 1997 ophthalmologist consulted 5 patients after nucleation but since 1998 to 1999 ophthalmologist consulted 14 patients to be evaluated and staging of tumor and planning of the treatment. From 19 patients retinoblastoma mostly less than 5 years (79%) and there is no other difference according to gender. Bone marrow aspiration was performed only 15 patients, 13 showed metastases on marrow.
Discussion
The diagnosis of retinoblastoma is established by recognition of typical clinical features of the tumor, ophthalmoscopic examination by ophthalmologist in combination with radiologic examination particularly ultrasonography and computed tomography. Bone marrow puncture and lumbar puncture are also needed. Donalson et al, found no sex predilection and we did not found difference according to gender in retinoblastoma patients. Some authors said that retinoblastoma cases usually found in children less than 5 years of age and in our retinoblastoma patients mostly in less than 5 years.
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Early recognition of this malignancy is important and life saving; however most of the patients in our series presented with was proptosis, which was very late. This probably reflects the condition in most developing countries, where late diagnosis is a rule. Diagnosis being made only after enlarged eye or gross orbital extension.
Treatment of retinoblastoma depends on the stage of the tumor at diagnosis; it is usually followed by long term follow up and periodic examination of the child. Treatment options vary and include: enucleation, total irradiation, focal irradiation, cryotherapy, photocoagulation and chemotherapy. Enucleation of the eye is still the commonest from of treatment and may result in complete cure. Retinoblastoma are very radiosensitive and radiotherapy is the cornerstone of conserva- tive management, usually to a total dose of 3500-4000 rads in three to four weeks. The indications for chemotherapy are not clearly established, and some controversy still exists about is value. Chemotherapy is generally used in patients with orbital, intracranial and metastatic disease. In most solid tumor patients chemotherapy is given before surgical treatment but in retinoblastoma pre-operative chemotherapy is not yet routine. Decision about further treatment enucleation, chemotherapy and radiotherapy depend on which stage, whether involvement is unilateral or bilateral, whether there is vision or any potential for vision, whether the tumor is confined to the globe or there is extension to the optic nerve. Pre-operative chemotherapy had been given in mostly patients since 1998-1999 because the patients commonly with metastatic disease (stage III-IV). From this study we are planning to evaluate the direct benefits of pre-operative chemotherapy for stage III an d IV retinoblastoma. The management of retinoblastoma can be extremely difficult, and physicians must often make difficult decisions about the use of various treatment modalities. The hope for the future is that more children will preserve the affected eye with some or all of its vision and with minimal side effects from treatment.
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In summary retinoblastoma patients in our department were mostly diagnosed at the age of less than 5 years and there was no gender preponderance. The most common primary condition on admission was proptosis. This advance stage at diagnosis made the prognosis of most of 'patients' grave.
